中元股份(300018.SZ):完成回購註銷168.6萬股限制性股票
格隆匯 7 月 17日丨中元股份(300018.SZ)公告,因公司2019年業績未達到公司2017年限制性股票激勵計劃首次授予第三個解除限售期規定的業績考核條件,按激勵計劃相關規定回購並註銷150名激勵對象第三個解除限售期未達到解除限售條件的168.6萬股限制性股票。
公司於2020年7月16日在中國證券登記結算有限責任公司深圳分公司完成了回購註銷手續,本次回購註銷完成後,公司總股本由48,251.7536萬股變更為48,083.1536萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.